Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
cyclophosphamide + prednisolone
- Development stage
- Unknown
- Lead developer
- Bayer HealthCare Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral, Intravenous
01
Overview
Cyclophosphamide + prednisolone is a combination chemotherapy regimen used in the treatment of various conditions including multiple myeloma, lymphoma, and membranous nephropathy. Cyclophosphamide is an alkylating agent that works by interfering with DNA replication in rapidly dividing cells, while prednisolone is a corticosteroid with anti-inflammatory and immunosuppressive properties. This combination can be administered in different dosing schedules, including continuous low-dose oral administration or intermittent intravenous administration, depending on the condition being treated and patient factors.
- Other names
- cyclophosphamide and prednisolonecyclophosphamide plus prednisolonecyclophosphamide-prednisolone
02
Targets
GR (Glucocorticoid receptor)DNA
Beyond the preview
Go deeper on cyclophosphamide + prednisolone.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on cyclophosphamide + prednisolone.